Non-steroidal anti-inflammatory drugs if combined with anti-histamine and anti-serotonin agents interfere with the bronchial and platelet effects of “platelet-activating factor” (PAF-acether)
- 1 August 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 82 (3-4) , 121-130
- https://doi.org/10.1016/0014-2999(82)90500-3
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Control of vascular permeability by polymorphonuclear leukocytes in inflammationNature, 1981
- Platelet-Activating Factor (PAF-Acether) Secretion from Platelets: Effect of Aggregating AgentsBritish Journal of Haematology, 1980
- The role of platelet-activating factor in platelet aggregationNature, 1979
- Secretable Storage Pools in PlateletsAnnual Review of Medicine, 1979
- Carrageenan and thrombin trigger prostaglandin synthetase-independent aggregation of rabbit platelets: inhibition by phospholipase A2 inhibitorsJournal of Pharmacy and Pharmacology, 1977
- Morphine and Ethanol: Selective Depletion of Regional Brain CalciumScience, 1974
- Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykininJournal of Pharmacy and Pharmacology, 1972
- Release of Vasoactive Substances from Guinea-Pig Lungs by Slow-Reacting Substance C and Arachidonic AcidPharmacology, 1971
- Synergistic effects of adrenaline and mepyramine on the anaphylactic reactions of the bronchi and pulmonary vessels in the guinea pig heart-lung-preparationNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1970
- Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory DrugsNature, 1969